Fycompa® (Perampanel) in LGS

New Treatment for Seizures

What is FYCOMPA (perampanel)?

FYCOMPA is a prescription medicine used alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures in people with epilepsy aged 4 and older. It is also used with other medicines to treat primary generalized tonic-clonic seizures in people with epilepsy aged 12 and older.

Watch an overview of Fycompa in LGS

– Presented by Dr. Michael Chez

Data from a recent study suggest that treatment with perampanel (Fycompa; Eisai) is safe and well-tolerated in patients with LGS. Findings were presented at the 2021 American Epilepsy Society (AES) Annual Meeting, December 3-7 in Chicago and virtually.

More information about medication access assistance to patients, caregivers, and their medical teams can be found at www.FYCOMPA.com.

READ MORE: Perampanel Effective, Well-Tolerated in Lennox-Gastaut Syndrome

The information here is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. Content provided is for informational purposes only. LGS Foundation is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health-related diagnosis or treatment options.